Leerink Partnrs Forecasts Cardinal Health Q1 Earnings

Cardinal Health, Inc. (NYSE:CAH - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2026 EPS estimates for shares of Cardinal Health in a research report issued on Tuesday, July 1st. Leerink Partnrs analyst M. Cherny anticipates that the company will post earnings of $2.17 per share for the quarter. The consensus estimate for Cardinal Health's current full-year earnings is $7.95 per share. Leerink Partnrs also issued estimates for Cardinal Health's Q2 2026 earnings at $2.18 EPS, Q3 2026 earnings at $2.69 EPS, Q4 2026 earnings at $2.27 EPS and FY2026 earnings at $9.31 EPS.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The firm's revenue for the quarter was up .0% on a year-over-year basis. During the same period in the previous year, the business earned $2.08 earnings per share.

CAH has been the subject of a number of other reports. Citigroup reissued a "neutral" rating and issued a $170.00 target price (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Bank of America increased their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Evercore ISI restated an "outperform" rating and set a $180.00 price objective (up from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Finally, UBS Group increased their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a research note on Tuesday, April 29th. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and an average price target of $157.43.

Cardinal Health Stock Performance

NYSE:CAH traded up $2.82 during trading hours on Wednesday, reaching $164.80. The stock had a trading volume of 1,234,057 shares, compared to its average volume of 2,245,561. The stock has a market capitalization of $39.33 billion, a PE ratio of 25.71, a PEG ratio of 1.60 and a beta of 0.68. Cardinal Health has a 52 week low of $93.17 and a 52 week high of $168.44. The company has a 50 day moving average price of $155.04 and a two-hundred day moving average price of $136.82.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.24%. The ex-dividend date of this dividend is Tuesday, July 1st. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is currently 31.83%.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Private Trust Co. NA raised its stake in shares of Cardinal Health by 11.0% during the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock valued at $110,000 after acquiring an additional 92 shares in the last quarter. SVB Wealth LLC purchased a new position in Cardinal Health during the 4th quarter worth $231,000. Fisher Asset Management LLC purchased a new position in Cardinal Health during the 4th quarter worth $368,000. Smartleaf Asset Management LLC raised its position in Cardinal Health by 37.4% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,378 shares of the company's stock valued at $163,000 after purchasing an additional 375 shares in the last quarter. Finally, Bailard Inc. lifted its holdings in shares of Cardinal Health by 3.0% in the 4th quarter. Bailard Inc. now owns 6,012 shares of the company's stock worth $711,000 after buying an additional 177 shares during the period. Institutional investors own 87.17% of the company's stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.